Innovations in therapies for heart valve disease

Muralidhar Padala1, William Brent Keeling, Robert A Guyton

  • 1Joseph B. Whitehead Department of Surgery, Division of Cardiothoracic Surgery, Emory University School of Medicine, GA, USA.

Insights

Heart valve disease is a major health issue, especially in adults, due to aging populations. This review covers new diagnostic and therapeutic technologies for heart valve dysfunction.

Area of Science:

  • Cardiology
  • Medical Technology
  • Surgical Innovation

Background:

  • Heart valve disease presents a significant health burden in developed nations, primarily driven by increased life expectancy and age-related valvular degeneration.
  • Uncorrected heart valve dysfunction leads to severe outcomes, including congestive heart failure, increased morbidity, and mortality.
  • Growing clinical evidence of valve disease's impact on all age groups has spurred interest and investment in advanced diagnosis and therapies.

Purpose of the Study:

  • To review recent advancements in heart valve therapies.
  • To critically evaluate the clinical need for these emerging technologies.
  • To discuss clinical experiences and outcomes associated with novel heart valve interventions.

Main Methods:

  • Literature review of current and emerging heart valve technologies.
  • Analysis of clinical evidence supporting new diagnostic and therapeutic approaches.
  • Appraisal of surgical, minimally invasive, and percutaneous treatment options.

Main Results:

  • A broad spectrum of surgical, minimally invasive, and percutaneous heart valve technologies are now available.
  • These technologies have expanded treatment options and transformed the surgical management of heart valve lesions.
  • The review synthesizes clinical data on the efficacy and application of various advanced heart valve interventions.

Conclusions:

  • Recent technological innovations offer improved options for managing heart valve disease.
  • Clinicians require a solid scientific foundation to integrate these new technologies effectively into practice.
  • The adoption of advanced heart valve therapies promises to enhance patient outcomes and reduce disease-related mortality.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...